BFC Planning, Inc.’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.24K Sell
8
-256
-97% -$118K ﹤0.01% 2734
2026
Q1
$127K Sell
264
-175
-40% -$89.6K 0.01% 1030
2025
Q4
$247K Buy
439
+176
+67% +$100K 0.01% 791
2025
Q3
$135K Buy
263
+260
+8,667% +$114K 0.01% 807
2025
Q2
$942 Buy
+3
New +$901 ﹤0.01% 2463
2025
Q1
– Sell
-7
Closed -$2.33K – 2711
2024
Q4
$2.33K Buy
+7
New +$2.37K ﹤0.01% 2249

Other funds holding MEDP

BFC Planning, Inc.'s MEDP Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Medpace (MEDP) stake by 97% in Q2 2026, selling an estimated $118K and leaving 8 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

BFC Planning, Inc. first reported a position in MEDP in Q4 2024 and has held it in 6 quarters since. The position peaked at $247K in Q4 2025. 703 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • BFC Planning, Inc. held 8 shares of Medpace worth $4.24K as of Q2 2026.
  • BFC Planning, Inc. sold 256 Medpace shares in Q2 2026, an estimated $118K.
  • Medpace made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2734 holding.
  • BFC Planning, Inc. first reported a position in Medpace in Q4 2024 and has held it in 6 quarters since.
  • BFC Planning, Inc.'s Medpace position peaked at $247K in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.